Powered by

Novartis Pharmaceuticals Agrees To Pay $678 Million To Settle Shepherd, Finkelman, Miller & Shah, LLP False Claims Act Qui Tam Case; Novartis Pharmaceuticals Agrees to Pay $678 Million to Settle Allegations of Illegal Kickbacks Involving Nine of the Compa

Jul 01, 2020 - PR Newswire

PR Newswire

James E. Miller of Shepherd, Finkelman, Miller & Shah, LLP ("SFMS")(http://www.sfmslaw.com), Lead Counsel for Plaintiff-Relator, Oswald Bilotta (the "Relator" or "Whistleblower"), announced today that Novartis Pharmaceuticals Corporation ("Novartis") has agreed to settle alleged violations of the False Claims Act based on a complaint filed by the Whistleblower in 2011 asserting that Novartis used "speaker programs" to pay physician speakers unlawful compensation in violation ...